{"product_id":"starhealth-pestle-analysis","title":"Star Health and Allied Insurance PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGain a competitive edge with our concise PESTLE Analysis of Star Health and Allied Insurance—revealing how political, economic, social, technological, legal and environmental forces will shape its growth. Perfect for investors and strategists needing fast, actionable insights. Purchase the full report to access detailed, ready-to-use intelligence and forecasts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare policy priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eShifts toward universal coverage — Ayushman Bharat (launched 2018, target 500 million beneficiaries) and state schemes — compress retail demand but expand secondary-market segments for Star Health as low-cost public cover fills primary needs.\u003c\/p\u003e\n\u003cp\u003ePublic–private partnerships and empanelment tie-ups open distribution and claims-settlement revenue streams.\u003c\/p\u003e\n\u003cp\u003ePolicy emphasis on preventive care and wellness (India’s public health spend ~1.3% of GDP) will push product redesign and pricing; election cycles can disrupt budget allocations and reimbursement timelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment subsidies and state tie-ups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernment-sponsored schemes and state empanelment decisions materially drive Star Health volumes and margins; competitive tenders compress pricing but broaden reach into tier-2\/3 markets, while reimbursement delays of six–nine months from some government programs create a tangible working-capital risk; greater policy harmonization across states would reduce operational complexity and lower administrative costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIRDAI’s reform agenda alignment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIRDAI’s pro-growth measures such as use-and-file, simplified KYC and product sandboxing have accelerated product approvals and market entry, enabling Star Health to scale retail and group offerings more rapidly. Political backing for higher insurance penetration has loosened distribution norms, supporting partnerships across banks, brokers and digital platforms. A policy reversal would increase compliance timelines and operating costs, slowing innovation and rollouts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFDI and diplomatic climate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStable FDI rules, including the 74% foreign investment cap in insurance, bolster Star Healths capital adequacy and enable tech partnerships; geopolitical shocks since 2022 have strained global healthcare supply chains, pushing claim-related costs higher and feeding into rising medical inflation (~10% annually). Government moves on data localization and the 2023 Digital Personal Data Protection environment shape vendor selection, while predictable policy lowers funding costs and supports geographic expansion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFDI cap: 74% in insurance\u003c\/li\u003e\n\u003cli\u003eMedical inflation: ~10% pa\u003c\/li\u003e\n\u003cli\u003eSupply-chain risk: elevated post-2022\u003c\/li\u003e\n\u003cli\u003eData rules: drive onshore vendors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health infrastructure investments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRising public health investments—still under 2% of GDP—are gradually lowering out-of-pocket burdens and expected to reduce claim severities for Star Health over time; Ayushman Bharat covers over 50 crore beneficiaries and expanded hospital capacity strengthens provider networks. New medical colleges (≈100+ since 2014) and bed additions improve network depth, but regional disparities keep claims inflation uneven, steering policy-driven regional expansion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic spend: \u0026lt;2% GDP\u003c\/li\u003e\n\u003cli\u003eAyushman Bharat: \u0026gt;50 crore beneficiaries\u003c\/li\u003e\n\u003cli\u003eNew medical colleges: ≈100+ since 2014\u003c\/li\u003e\n\u003cli\u003eClaims inflation: uneven regionally — informs expansion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy push for universal health cover boosts institutional volumes, compresses retail margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolicy push for universal cover (Ayushman Bharat \u0026gt;50 crore beneficiaries) expands institutional volumes while compressing retail margins; IRDAI reforms (use-and-file, sandboxing) speed product launches but a 74% FDI cap and regulatory shifts can affect capital and partnerships. Reimbursement delays (6–9 months) and ~10% medical inflation raise working-capital and claim-cost risks; state-level divergence increases operational complexity.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAyushman Bharat\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;50 crore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic health spend\u003c\/td\u003e\n\u003ctd\u003e~1.3–1.6% GDP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFDI cap\u003c\/td\u003e\n\u003ctd\u003e74%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical inflation\u003c\/td\u003e\n\u003ctd\u003e~10% pa\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReimbursement lag\u003c\/td\u003e\n\u003ctd\u003e6–9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Star Health and Allied Insurance across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with each section backed by relevant data and current trends. Designed for executives and investors, the analysis offers forward-looking insights to identify risks, opportunities, and strategic priorities specific to the insurer's market and regulatory context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, PESTLE-segmented summary of Star Health and Allied Insurance that’s easy to drop into presentations, editable for regional or business-line notes, and shareable across teams to streamline external risk discussions and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical inflation and cost trend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHealthcare inflation in India generally outpaces CPI by about 2–4 percentage points, increasing pressure on Star Health’s loss ratios as hospital input costs and claim severities rise. Rising provider tariffs lift claim amounts and force higher renewal pricing across portfolios. Product redesigns and wider adoption of co-pay features have been used to manage the trend, but persistent inflation elevates affordability risk for price-sensitive segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGDP growth and employment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIndia's GDP is projected at about 6.8% for 2024 by the IMF, supporting higher disposable incomes and stronger group policy uptake for Star Health; IRDAI reported health GWP growth around 15% in FY24 to roughly INR 58,000 crore, reflecting demand expansion. Formalization—rising payroll coverage via EPFO—boosts payroll-linked penetration. Economic slowdowns can weaken persistency and cross-sell, while cyclicality in sectors like manufacturing and real estate raises corporate claim volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest rates and investment income\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInsurers like Star Health rely on investment income to offset underwriting variability; India policy rates stood at a repo rate of 6.50% (July 2025) supporting higher fixed-income yields. Rising 10-year G-sec yields near 7.2% boost solvency and earnings, while falling rates compress spreads. Asset-liability duration matching is critical for guaranteed features, and equity-market swings (India VIX ~13 in 2024) affect equity-booked returns.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency and import dependencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eImported medical devices account for about 80% of India’s device market by value and APIs nearly 60% rely on China, making Star Health claims sensitive to INR depreciation; past INR weakness amplified equipment- and drug-linked claim costs. FX swings widen cost gaps across therapies, hedging occurs indirectly via pricing cycles and provider contracts, and urban\/metro customers face greater exposure to high-cost imported procedures.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDevice imports ~80% by value\u003c\/li\u003e\n\u003cli\u003eAPI dependence ~60% from China\u003c\/li\u003e\n\u003cli\u003eHedging via pricing cycles\/provider contracts\u003c\/li\u003e\n\u003cli\u003eHigher exposure in urban\/metro segments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHousehold affordability and penetration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHousehold affordability and low insurance penetration (approx 3.2% of GDP in 2023, IRDAI) provide a large growth runway but demand is highly price-elastic. Tier-2\/3 uptake depends on sachet products and family-floater plans. Premium tax treatment and GST rates materially influence take-up while flexible monthly\/EMI-style payments reduce lapse risk.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePenetration: ~3.2% (IRDAI 2023)\u003c\/li\u003e\n\u003cli\u003eTier-2\/3: sachet + family floaters\u003c\/li\u003e\n\u003cli\u003eTax\/GST: affects affordability\u003c\/li\u003e\n\u003cli\u003eFlexible pay: lowers lapses\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy push for universal health cover boosts institutional volumes, compresses retail margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHealthcare inflation +2–4pp raises Star Health claim severity and pricing pressure; FY24 health GWP grew ~15% to ~INR 58,000cr while GDP ~6.8% (IMF 2024) supports demand; policy repo 6.50% (Jul 2025) and 10y G-sec ~7.2% aid investment income; device imports ~80% and API reliance ~60% increase FX-linked claim risk; penetration ~3.2% (IRDAI 2023).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealthcare inflation\u003c\/td\u003e\n\u003ctd\u003e+2–4 pp\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth GWP FY24\u003c\/td\u003e\n\u003ctd\u003e~INR 58,000cr (+15%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGDP 2024 (IMF)\u003c\/td\u003e\n\u003ctd\u003e6.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepo (Jul 2025)\u003c\/td\u003e\n\u003ctd\u003e6.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10y G-sec\u003c\/td\u003e\n\u003ctd\u003e~7.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice imports\u003c\/td\u003e\n\u003ctd\u003e~80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAPI dependence\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePenetration (IRDAI 2023)\u003c\/td\u003e\n\u003ctd\u003e~3.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eStar Health and Allied Insurance PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact PESTLE analysis of Star Health and Allied Insurance you’ll receive after purchase—fully formatted and ready to use. It presents political, economic, social, technological, legal and environmental factors in the same structure and detail as the downloadable file. No placeholders or teasers—this is the final document available immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162724348281,"sku":"starhealth-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/starhealth-pestle-analysis.png?v=1762707647","url":"https:\/\/portersfiveforce.com\/products\/starhealth-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}